(VIANEWS) – Gilead Sciences (GILD), U.S. Energy Corp. (USEG), Chimera Investment Corporation (CIM) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio up to now. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. Gilead Sciences (GILD)
838.89% Payout Ratio
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.
Earnings Per Share
As for profitability, Gilead Sciences has a trailing twelve months EPS of $4.5.
PE Ratio
Gilead Sciences has a trailing twelve months price to earnings ratio of 15.13. Meaning, the purchaser of the share is investing $15.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.39%.
Volume
Today’s last reported volume for Gilead Sciences is 5227090 which is 29.7% below its average volume of 7436250.
2. U.S. Energy Corp. (USEG)
180% Payout Ratio
U.S. Energy Corp., an independent energy company, focuses on the acquisition, exploration, and development of oil and natural gas properties in the United States. It holds interests in various oil and gas properties in the Williston Basin in North Dakota, the Permian Basin in New Mexico, the Powder River Basin in Wyoming, and in the Gulf Coast of Texas. As of December 31, 2020, the company had an estimated proved reserves of 1,255,236 barrel of oil equivalent; and 134 gross producing wells. U.S. Energy Corp. was founded in 1966 and is based in Houston, Texas.
Earnings Per Share
As for profitability, U.S. Energy Corp. has a trailing twelve months EPS of $-1.61.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -71.42%.
Volume
Today’s last reported volume for U.S. Energy Corp. is 32375 which is 64.19% below its average volume of 90425.
3. Chimera Investment Corporation (CIM)
113.73% Payout Ratio
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency and non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, and other real estate related securities. It has elected to be taxed as a REIT and would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its shareholders. The company was incorporated in 2007 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Chimera Investment Corporation has a trailing twelve months EPS of $1.53.
PE Ratio
Chimera Investment Corporation has a trailing twelve months price to earnings ratio of 8.18. Meaning, the purchaser of the share is investing $8.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.49%.
Moving Average
Chimera Investment Corporation’s value is below its 50-day moving average of $12.66 and way below its 200-day moving average of $14.10.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 16.7% and 10.3%, respectively.
Yearly Top and Bottom Value
Chimera Investment Corporation’s stock is valued at $12.51 at 08:23 EST, way below its 52-week high of $19.47 and way higher than its 52-week low of $11.29.
Sales Growth
Chimera Investment Corporation’s sales growth is 8.4% for the current quarter and negative 16.4% for the next.
4. CBRE Clarion Global Real Estate Income Fund (IGR)
85.71% Payout Ratio
CBRE Clarion Global Real Estate Income Fund specializes in investments in various property types, including office, retail, diversified, apartments, industrials, hotels, healthcare, and storage. It invests in the public equity markets across the developed markets of North America, Europe, Australia, and Asia. The fund seeks to invest in stocks of companies operating across the real estate sector including REITs. It invests in stocks of companies across diversified market capitalizations. The fund employs fundamental analysis to create its portfolio. It conducts in-house research to make its investments.
Earnings Per Share
As for profitability, CBRE Clarion Global Real Estate Income Fund has a trailing twelve months EPS of $0.84.
PE Ratio
CBRE Clarion Global Real Estate Income Fund has a trailing twelve months price to earnings ratio of 6.04. Meaning, the purchaser of the share is investing $6.04 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.99%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 6.9%, now sitting on 43.08M for the twelve trailing months.
Yearly Top and Bottom Value
CBRE Clarion Global Real Estate Income Fund’s stock is valued at $5.07 at 08:23 EST, below its 52-week high of $5.62 and way higher than its 52-week low of $3.88.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jun 20, 2024, the estimated forward annual dividend rate is 0.72 and the estimated forward annual dividend yield is 14.2%.
5. Nuveen New York AMT (NRK)
53.81% Payout Ratio
Nuveen New York AMT-Free Quality Municipal Income Fund is a closed ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of New York. The fund invests in undervalued municipal securities and other related investments the income, covered by insurance from insurers with a claims-paying ability, exempt from regular federal and New York income tax and are rated Baa, BBB or better and having an average maturity of 15.98 years. It employs fundamental analysis with bottom-up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the Standard & Poor's (S&P) New York Municipal Bond Index and the Standard & Poor's (S&P) Insured National Municipal Bond Index. It was formerly known as Nuveen New York AMT-Free Municipal Income Fund. Nuveen New York AMT-Free Quality Municipal Income Fund was formed on July 29, 2002 and is domiciled in the United States.
Earnings Per Share
As for profitability, Nuveen New York AMT has a trailing twelve months EPS of $0.84.
PE Ratio
Nuveen New York AMT has a trailing twelve months price to earnings ratio of 13.13. Meaning, the purchaser of the share is investing $13.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.09%.
Yearly Top and Bottom Value
Nuveen New York AMT’s stock is valued at $11.03 at 08:23 EST, under its 52-week high of $11.20 and way above its 52-week low of $8.95.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of $1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing $1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
